The DOI matches its Crossref record; 361 of the 361 references it cites were found in a registry or an index.
Pathophysiology of obesity and its associated diseases
Open accessAbstract
The occurrence of obesity has increased across the whole world. Many epidemiological studies have indicated that obesity strongly contributes to the development of cancer, cardiovascular diseases, type 2 diabetes, liver diseases and other disorders, accounting for a heavy burden on the public and on health-care systems every year. Excess energy uptake induces adipocyte hypertrophy, hyperplasia and formation of visceral fat in other non-adipose tissues to evoke cardiovascular disease, liver diseases. Adipose tissue can also secrete adipokines and inflammatory cytokines to affect the local microenvironment, induce insulin resistance, hyperglycemia, and activate associated inflammatory signaling pathways. This further exacerbates the development and progression of obesity-associated diseases. Although some progress in the treatment of obesity has been achieved in preclinical and clinical studies, the progression and pathogenesis of obesity-induced diseases are complex and unclear. We still need to understand their links to better guide the treatment of obesity and associated diseases. In this review, we review the links between obesity and other diseases, with a view to improve the future management and treatment of obesity and its co-morbidities.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Items 201–361 of 361
Adipose tissue, obesity and non-alcoholic fatty liver disease
Polyzos, S. A., Kountouras, J., & Mantzoros, C. S. (2017) · Minerva Endocrinology · doi:10.23736/s0391-1977.16.02563-3 · Cited by 207
Epidemiology, Pathogenesis, Diagnosis and Emerging Treatment of Nonalcoholic Fatty Liver Disease
Makri, E., Goulas, A., & Polyzos, S. A. (2021) · Archives of Medical Research · doi:10.1016/j.arcmed.2020.11.010 · Cited by 204
Differential effects of leptin on cancer in vitro
Somasundar, P., Yu, A. K., Vona-Davis, L., & McFadden, D. W. (2003) · Journal of Surgical Research · doi:10.1016/s0022-4804(03)00166-5 · Cited by 202
Lin, W., Tsai, W., Shao, R., Wu, G., Peng, L. F., Barlow, L. L., Chung, W. J., Zhang, L., Zhao, H., Jang, J., et al. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.03.008 · Cited by 193
Contribution of adipose tissue to development of cancer
Cozzo, A. J., Fuller, A. M., & Makowski, L. (2017) · Comprehensive Physiology · doi:10.1002/cphy.c170008 · Cited by 188
The ins and outs of leptin receptor activation
Zabeau, L., Lavens, D., Peelman, F., Eyckerman, S., Vandekerckhove, J., & Tavernier, J. (2003) · FEBS Letters · doi:10.1016/s0014-5793(03)00440-x · Cited by 188
Lipid metabolism and signaling in cardiac lipotoxicity
D'Souza, K., Nzirorera, C., & Kienesberger, P. C. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2016.02.016 · Cited by 188
Ohkuma, T., Peters, S. A. E., & Woodward, M. (2018) · Diabetologia · doi:10.1007/s00125-018-4664-5 · Cited by 188
Epicardial Adipose Tissue: Clinical Biomarker of Cardio-Metabolic Risk
Villasante Fricke, A. C., & Iacobellis, G. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20235989 · Cited by 184
Adipose Tissue Fibrosis in Obesity: Etiology and Challenges
Marcelin, G., Gautier, E. L., & Clément, K. (2022) · Annual Review of Physiology · doi:10.1146/annurev-physiol-060721-092930 · Cited by 180
Miller, R. A., Chu, Q., Le Lay, J., Scherer, P. E., Ahima, R. S., Kaestner, K. H., Foretz, M., Viollet, B., & Birnbaum, M. J. (2011) · Journal of Clinical Investigation · doi:10.1172/jci45942 · Cited by 179
Patel, N. S., Doycheva, I., Peterson, M. R., Hooker, J., Kisselva, T., Schnabl, B., Seki, E., Sirlin, C. B., & Loomba, R. (2015) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2014.08.039 · Cited by 173
Mechanisms linking obesity and cancer
Louie, S. M., Roberts, L. S., & Nomura, D. K. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2013.02.008 · Cited by 173
Association of left ventricular hypertrophy with metabolic risk factors: the HyperGEN study
de Simone, G., Palmieri, V., Bella, J. N., Celentano, A., Hong, Y., Oberman, A., Kitzman, D. W., Hopkins, P. N., Arnett, D. K., & Devereux, R. B. (2002) · Journal of Hypertension · doi:10.1097/00004872-200202000-00024 · Cited by 171
Adiponectin, lipids and atherosclerosis
Katsiki, N., Mantzoros, C., & Mikhailidis, D. P. (2017) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000431 · Cited by 170
Signaling pathways linking inflammation to insulin resistance
Zand, H., Morshedzadeh, N., & Naghashian, F. (2017) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2017.03.006 · Cited by 169
Abnormalities of lipid metabolism in hepatitis C virus infection
Negro, F. (2010) · Gut · doi:10.1136/gut.2009.192732 · Cited by 162
Benomar, Y., Naour, N., Aubourg, A., Bailleux, V., Gertler, A., Djiane, J., Guerre-Millo, M., & Taouis, M. (2006) · Endocrinology · doi:10.1210/en.2005-1464 · Cited by 162
Adiponectin signaling in the liver
Combs, T. P., & Marliss, E. B. (2013) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-013-9280-6 · Cited by 161
Obesity, insulin resistance, NASH and hepatocellular carcinoma
Yu, J., Shen, J., Sun, T. T., Zhang, X., & Wong, N. (2013) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2013.07.003 · Cited by 161
Barregård, L., Möller, P., Henriksen, T., Mistry, V., Koppen, G., Rössner, P., Šrám, R. J., Weimann, A., Poulsen, H. E., Nataf, R., et al. (2012) · Antioxidants and Redox Signaling · doi:10.1089/ars.2012.4714 · Cited by 159
The Obesity Paradox in Cancer: Epidemiologic Insights and Perspectives
Lee, D. H., & Giovannucci, E. L. (2019) · Current Nutrition Reports · doi:10.1007/s13668-019-00280-6 · Cited by 159
Mechanisms by which adiponectin reverses high fat diet-induced insulin resistance in mice
Li, X., Zhang, D., Vatner, D. F., Goedeke, L., Hirabara, S. M., Zhang, Y., Perry, R. J., & Shulman, G. I. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1922169117 · Cited by 158
Diet-induced weight loss reduces colorectal inflammation: implications for colorectal carcinogenesis
Pendyala, S., Neff, L. M., Suárez‐Fariñas, M., & Holt, P. R. (2010) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.110.002683 · Cited by 156
Maguire, O. A. B., Ackerman, S. E., Szwed, S. K., Maganti, A. V., Marchildon, F., Huang, X., Kramer, D. J., Rosas-Villegas, A., Gelfer, R., Turner, L. E., et al. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2021.01.018 · Cited by 156
Insulin resistance, adiponectin, cytokines in NASH: Which is the best target to treat?
Larter, C. Z., & Farrell, G. C. (2005) · Journal of Hepatology · doi:10.1016/j.jhep.2005.11.030 · Cited by 155
Macrophage infiltration into obese adipose tissues suppresses the induction of UCP1 level in mice
Sakamoto, T., Nitta, T., Maruno, K., Yeh, Y., Kuwata, H., Tomita, K., Goto, T., Takahashi, N., & Kawada, T. (2016) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00028.2015 · Cited by 153
Moon, H.-S., Matarese, G., Brennan, A. M., Chamberland, J. P., Liu, X., Fiorenza, C. G., Mylvaganam, G. H., Abanni, L., Carbone, F., Williams, C. J., et al. (2011) · Diabetes · doi:10.2337/db10-1791 · Cited by 151
Is There a Rationale for Angiotensin Blockade in the Management of Obesity Hypertension?
Sharma, A. M. (2004) · Hypertension · doi:10.1161/01.hyp.0000132568.71409.a2 · Cited by 150
Zhang, N., Liu, X., Zhuang, L., Liu, X., Zhao, H., Shan, Y., Liu, Z., Li, F., Wang, Y., & Fang, J. (2019) · Regulatory Toxicology and Pharmacology · doi:10.1016/j.yrtph.2019.104544 · Cited by 150
Adiponectin as Link Factor between Adipose Tissue and Cancer
Zazzo, E. D., Polito, R., Bartollino, S., Nigro, E., Porcile, C., Bianco, A., Daniele, A., & Moncharmont, B. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20040839 · Cited by 144
Bariatric Surgery to Treat Obesity
Kissler, H. J., & Settmacher, U. (2013) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2012.12.004 · Cited by 141
Hepatic energy metabolism in human diabetes mellitus, obesity and non-alcoholic fatty liver disease
Koliaki, C. C., & Roden, M. (2013) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2013.06.002 · Cited by 140
Functional and structural features of adipokine family
Raucci, R., Rusolo, F., Sharma, A., Colonna, G., Castello, G., & Costantini, S. (2012) · Cytokine · doi:10.1016/j.cyto.2012.08.036 · Cited by 140
Perivascular adipose tissue and coronary atherosclerosis
Mâncio, J., Oikonomou, E. K., & Antoniades, C. A. (2018) · Heart · doi:10.1136/heartjnl-2017-312324 · Cited by 140
Moro, C., Klimčáková, E., Lolmède, K., Berlan, M., Lafontan, M., Štich, V., Bouloumié, A., Galitzky, J., Arner, P., & Langin, D. (2007) · Diabetologia · doi:10.1007/s00125-007-0614-3 · Cited by 135
Everhart, J. E., Lok, A. S.-F., Kim, H., Morgan, T. R. M., Lindsay, K. L., Chung, R. T., Bonkovsky, H. L., & Ghany, M. G. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.05.007 · Cited by 134
Obesity and gastrointestinal cancer
Donohoe, C. L., Pidgeon, G. P., Lysaght, J., & Reynolds, J. V. (2010) · British journal of surgery · doi:10.1002/bjs.7079 · Cited by 131
Pancreatic cancer associated with obesity and diabetes: an alternative approach for its targeting
Pothuraju, R., Rachagani, S., Junker, W. M., Chaudhary, S., Saraswathi, V., Kaur, S., & Batra, S. K. (2018) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-018-0963-4 · Cited by 129
Obesity and Thyroid Cancer Risk: An Update
Franchini, F., Palatucci, G., Colao, A., Ungaro, P., Macchia, P. E., & Nettore, I. C. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph19031116 · Cited by 128
Corey, K. E., & Kaplan, L. M. (2013) · Clinics in Liver Disease · doi:10.1016/j.cld.2013.09.019 · Cited by 126
Obesity and prostate cancer: A narrative review
Wilson, R. L., Taaffe, D. R., Newton, R. U., Hart, N. H., Lyons‐Wall, P., & Galvao, D. A. (2021) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2021.103543 · Cited by 123
Adipose tissue production of hepatocyte growth factor contributes to elevated serum HGF in obesity
Bell, L. N., Ward, J. L., Degawa-Yamauchi, M., Bovenkerk, J. E., Jones, R., Cacucci, B. M., Gupta, C. E., Sheridan, C., Sheridan, K., Shankar, S. S., et al. (2006) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00174.2006 · Cited by 121
A systematic review of the impact of weight loss on cancer incidence and mortality
Birks, S., Peeters, A., Backholer, K., O'Brien, P., & Brown, W. A. (2012) · Obesity Reviews · doi:10.1111/j.1467-789x.2012.01010.x · Cited by 121
Growth hormone is a positive regulator of adiponectin receptor 2 in 3T3‐L1 adipocytes
Faßhauer, M., Klein, J. C., Kralisch, S., Klier, M., Lössner, U., Blüher, M., & Paschke, R. (2004) · FEBS Letters · doi:10.1016/s0014-5793(03)01525-4 · Cited by 121
β‐Adrenergic stimulation of interleukin‐1α and interleukin‐6 expression in mouse brown adipocytes
Burýšek, L., & Houštěk, J. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)00671-6 · Cited by 119
Mittendorfer, B., Horowitz, J. F., DePaoli, A. M., Mccamish, M. A., Patterson, B. W., & Klein, S. (2011) · Diabetes · doi:10.2337/db10-1302 · Cited by 119
Chang, L., Xiong, W., Zhao, X., Fan, Y., Guo, Y., Garcia-Barrio, M. T., Zhang, J., Jiang, Z., Lin, J. D., & Chen, Y. (2018) · Circulation · doi:10.1161/circulationaha.117.029972 · Cited by 119
Leptin promotes breast cancer cell migration and invasion via IL-18 expression and secretion
Li, K., Wei, L., Huang, Y., Wu, Y., SU, M., Pang, X., Wang, N., Ji, F., Zhong, C., & Chen, T. (2016) · International Journal of Oncology · doi:10.3892/ijo.2016.3483 · Cited by 116
Alternative Mitophagy Protects the Heart Against Obesity-Associated Cardiomyopathy
Tong, M., Saito, T., Zhai, P., Oka, S.-I., Mizushima, W., Nakamura, M., Ikeda, S., Shirakabe, A., & Sadoshima, J. (2021) · Circulation Research · doi:10.1161/circresaha.121.319377 · Cited by 115
Macronutrients and the Adipose-Liver Axis in Obesity and Fatty Liver
Duwaerts, C. C., & Maher, J. J. (2019) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2019.02.001 · Cited by 114
Leptin–cytokine crosstalk in breast cancer
Newman, G. W., & Gonzalez-Perez, R. R. (2013) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2013.03.025 · Cited by 113
Postmenopausal Sex Hormones in Relation to Body Fat Distribution
Liedtke, S., Schmidt, M. E., Vrieling, A., Lukanova, A., Becker, S., Kaaks, R., Zaineddin, A. K., Buck, K., Benner, A., Chang‐Claude, J., et al. (2012) · Obesity · doi:10.1038/oby.2011.383 · Cited by 110
Yamaguchi, A., Tazuma, S., Nishioka, T., Ohishi, W., Hyogo, H., Nomura, S., & Chayama, K. (2005) · Digestive Diseases and Sciences · doi:10.1007/s10620-005-2788-1 · Cited by 109
Harmon, J. S., Gleason, C. E., Tanaka, Y., Oseid, E. A., Hunter-Berger, K. K., & Robertson, R. P. (1999) · Diabetes · doi:10.2337/diabetes.48.10.1995 · Cited by 108
Coenen, K. R., Gruen, M. L., Chait, A., & Hasty, A. H. (2007) · Diabetes · doi:10.2337/db06-1375 · Cited by 108
The Role of Obesity-Induced Perivascular Adipose Tissue (PVAT) Dysfunction in Vascular Homeostasis
Stanek, A., Brożyna-Tkaczyk, K., & Myśliński, W. (2021) · Nutrients · doi:10.3390/nu13113843 · Cited by 108
Omics Biomarkers in Obesity: Novel Etiological Insights and Targets for Precision Prevention
Aleksandrova, K., Rodrigues, C. E., Floegel, A., & Ahrens, W. (2020) · Current Obesity Reports · doi:10.1007/s13679-020-00393-y · Cited by 104
Obesity: an independent risk factor for systemic oxidative stress.
Khan, N. I., Naz, L., & Yasmeen, G. (2006) · PubMed · Cited by 98
Impact of obesity and overweight on DNA stability: Few facts and many hypotheses
Setayesh, T., Nersesyan, A., Mišík, M., Ferk, F., Langie, S., Andrade, V. M., Haslberger, A., & Knasmüller, S. (2018) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2018.07.001 · Cited by 98
An update on brown adipose tissue biology: a discussion of recent findings
Gaspar, R. C., Pauli, J. R., Shulman, G. I., & Muñoz, V. R. (2021) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00310.2020 · Cited by 98
MAP Kinase-Interacting Kinases—Emerging Targets against Cancer
Diab, S., Kumarasiri, M., Yu, M., Teo, T., Proud, C. G., Milne, R. W., & Wang, S. (2014) · Chemistry & Biology · doi:10.1016/j.chembiol.2014.01.011 · Cited by 97
Self-citationAkoumianakis, I., Tarun, A., & Antoniades, C. A. (2016) · British Journal of Pharmacology · doi:10.1111/bph.13666 · Cited by 93
Muris, D. M. J., Houben, A. J. H. M., Schram, M. T., & Stehouwer, C. D. A. (2013) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-012-9231-7 · Cited by 91
Diabetes and obesity: therapeutic targeting and risk reduction – a complex interplay
Niswender, K. D. (2009) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2009.01175.x · Cited by 89
Bariatric surgery for treatment of obesity
Eldar, S., Heneghan, H. M., Brethauer, S. A., & Schauer, P. R. (2011) · International Journal of Obesity · doi:10.1038/ijo.2011.142 · Cited by 89
Leptin-induced signaling pathways in cancer cell migration and invasion
Ghasemi, A., Saeidi, J., Azimi–Nezhad, M., & Hashemy, S. I. (2019) · Cellular Oncology · doi:10.1007/s13402-019-00428-0 · Cited by 89
Sphingolipids Function as Downstream Effectors of a Fungal PAQR
Villa, N., Kupchak, B. R., Garitaonandia, I., et al. (2008) · Molecular Pharmacology · doi:10.1124/mol.108.049809 · Cited by 87
Cannone, V., Cabassi, A., Volpi, R., & Burnett, J. C. J. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20133265 · Cited by 85
Adiponectin Deficiency Limits Tumor Vascularization in the MMTV-PyV-mT Mouse Model of Mammary Cancer
Denzel, M. S., Hebbard, L., Shostak, G., Shapiro, L. S., Cardiff, R. D., & Ranscht, B. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-2661 · Cited by 84
Recent Updates on Obesity Treatments: Available Drugs and Future Directions
Dragano, N. R. V., Fernø, J., Diéguez, C., López, M., & Milbank, E. (2020) · Neuroscience · doi:10.1016/j.neuroscience.2020.04.034 · Cited by 84
The Crucial Role of C18-Cer in Fat-Induced Skeletal Muscle Insulin Resistance
Błachnio-Zabielska, A. U., Chacińska, M., Vendelbo, M. H., & Zabielski, P. (2016) · Cellular Physiology and Biochemistry · doi:10.1159/000453174 · Cited by 83
Mechanisms linking adipose tissue inflammation to cardiac hypertrophy and fibrosis
Anthony, S., Guarnieri, A., Gozdiff, A., Helsley, R. N., Owens, A. P., & Tranter, M. (2019) · Clinical Science · doi:10.1042/cs20190578 · Cited by 82
Xiong, S., Salazar, G., Patrushev, N. A., Ma, M., Forouzandeh, F., Hilenski, L. L., & Alexander, R. W. (2013) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.112.301019 · Cited by 81
Mechanistic Links between Obesity, Insulin, and Cancer
Perry, R. J., & Shulman, G. I. (2020) · Trends in cancer · doi:10.1016/j.trecan.2019.12.003 · Cited by 81
Adipose stem cell niche reprograms the colorectal cancer stem cell metastatic machinery
Di Franco, S., Bianca, P., Sardina, D. S., Turdo, A., Gaggianesi, M., Veschi, V., Nicotra, A., Mangiapane, L. R., Lo Iacono, M., Pillitteri, I., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-25333-9 · Cited by 80
Natriuretic peptide control of energy balance and glucose homeostasis
Coué, M., & Moro, C. (2015) · Biochimie · doi:10.1016/j.biochi.2015.05.017 · Cited by 78
Surgical obesity treatment and the risk of heart failure
Jamaly, S., Carlsson, L. M. S., Peltonen, M., Jacobson, P., & Karason, K. (2019) · European Heart Journal · doi:10.1093/eurheartj/ehz295 · Cited by 78
Cai, C. X., Buddha, H., Castelino‐Prabhu, S., Zhang, Z., Britton, R. S., Bacon, B. R., & Neuschwander‐Tetri, B. A. (2017) · Digestive Diseases and Sciences · doi:10.1007/s10620-017-4470-9 · Cited by 77
The intersection of nonalcoholic fatty liver disease and obesity
Baidal, J. W., & Lavine, J. E. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aad8390 · Cited by 75
Cellular mechanisms linking cancers to obesity
Liu, X., Pedersen, L., & Halberg, N. (2021) · Cell Stress · doi:10.15698/cst2021.05.248 · Cited by 75
Central angiotensin II has catabolic action at white and brown adipose tissue
de Kloet, A. D., Krause, E. G., Scott, K. A., Foster, M. T., Herman, J. P., Sakai, R. R., Seeley, R. J., & Woods, S. C. (2011) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00307.2011 · Cited by 74
Pham, D., & Park, P. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22031444 · Cited by 74
Obesity as a risk factor for malignant melanoma and non-melanoma skin cancer
Karimi, K., Lindgren, T., Koch, C. A., & Brodell, R. T. (2016) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-016-9393-9 · Cited by 73
Serum leptin and adiponectin levels and risk of renal cell carcinoma
Liao, L. M., Schwartz, K., Pollak, M., Graubard, B. I., Li, Z., Ruterbusch, J. J., Rothman, N., Davis, F. G., Wacholder, S., Colt, J. S., et al. (2013) · Obesity · doi:10.1002/oby.20138 · Cited by 71
Than, A., Xu, S., Li, R., Leow, M. K., Sun, L., & Chen, P. (2017) · Signal Transduction and Targeted Therapy · doi:10.1038/sigtrans.2017.22 · Cited by 71
Leptin, Both Bad and Good Actor in Cancer
Jiménez‐Cortegana, C., López-Saavedra, A., Sánchez-Jiménez, F., Pérez‐Pérez, A., Castiñeiras, J., Virizuela-Echaburu, J. A., de la Cruz‐Merino, L., & Sánchez‐Margalet, V. (2021) · Biomolecules · doi:10.3390/biom11060913 · Cited by 71
The obesity paradox in cancer: clinical insights and perspectives
Trestini, I., Carbognin, L., Bonaiuto, C., Tortora, G., & Bria, E. (2018) · Eating and Weight Disorders - Studies on Anorexia Bulimia and Obesity · doi:10.1007/s40519-018-0489-y · Cited by 70
Pancreatic cancer and obesity: epidemiology, mechanism, and preventive strategies
Rawla, P., Thandra, K. C., & Sunkara, T. (2019) · Clinical Journal of Gastroenterology · doi:10.1007/s12328-019-00953-3 · Cited by 70
Comparative Secretome Analyses of Primary Murine White and Brown Adipocytes Reveal Novel Adipokines
Khan, A. A., Hansson, J., Weber, P., Föehr, S., Krijgsveld, J., Herzig, S., & Scheideler, M. (2018) · Molecular & Cellular Proteomics · doi:10.1074/mcp.ra118.000704 · Cited by 68
Lipid mechanisms in hallmarks of cancer
Molendijk, J., Robinson, H., Djurić, Z., & Hill, M. M. C. (2019) · Molecular Omics · doi:10.1039/c9mo00128j · Cited by 68
Askarpour, M., Alizadeh, S., Hadi, A., Symonds, M. E., Miraghajani, M. S., Sheikhi, A., & Ghaedi, E. (2020) · Hormone and Metabolic Research · doi:10.1055/a-1129-6785 · Cited by 68
Chechi, K., Voisine, P., Mathieu, P., Laplante, M., Bonnet, S., Picard, F., Joubert, P., & Richard, D. (2017) · Scientific Reports · doi:10.1038/s41598-017-15501-7 · Cited by 67
Introduction to the Obesity, Metabolic Syndrome, and CVD Compendium
Moore, K. J., & Shah, R. V. (2020) · Circulation Research · doi:10.1161/circresaha.120.317240 · Cited by 67
Progress in Pharmacotherapy for Obesity
Yanovski, S. Z., & Yanovski, J. A. (2021) · JAMA · doi:10.1001/jama.2021.9486 · Cited by 67
Ectopic fat deposition and global cardiometabolic risk: New paradigm in cardiovascular medicine
Shimabukuro, M., Kozuka, C., Taira, S.-I., Yabiku, K., Dagvasumberel, M., Ishida, M., Matsumoto, S., Yagi, S., Fukuda, D., Yamakawa, K., et al. (2013) · The Journal of Medical Investigation · doi:10.2152/jmi.60.1 · Cited by 66
The limits and challenges of antiobesity pharmacotherapy
Gadde, K. M., & Atkins, K. D. (2020) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2020.1748599 · Cited by 65
Inhibitory actions of ceramide upon PKC-ε/ERK interactions
Bourbon, N. A., Yun, J. K., Berkey, D., Wang, Y., & KESTER, M. A. (2001) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.2001.280.6.c1403 · Cited by 65
Rathmell, J. C. (2021) · New England Journal of Medicine · doi:10.1056/nejmcibr2035081 · Cited by 65
Impaired atrial natriuretic peptide-mediated lipolysis in obesity
Rydén, M., Bäckdahl, J., Petrus, P., Thorell, A., Gao, H., Coué, M., Langin, D., Moro, C., & Arner, P. (2015) · International Journal of Obesity · doi:10.1038/ijo.2015.222 · Cited by 64
Vascular Actions of Angiotensin 1–7 in the Human Microcirculation: Novel Role for Telomerase
Durand, M. J., Zinkevich, N. S., Riedel, M. J., Gutterman, D. D., Nasci, V. L., Salato, V. K., Hijjawi, J. B., Reuben, C. F., North, P. E., & Beyer, A. (2016) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.116.307518 · Cited by 63
Update on the Development of MNK Inhibitors as Therapeutic Agents
Xu, W., Kannan, S., Verma, C. S., & Nacro, K. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.1c00368 · Cited by 63
Oxidative Stress and DNA Damage in Obesity-Related Tumorigenesis
Cerdá, C., Sánchez, C., Climent, B. P., Vázquez, A., Iradi, A., Amrani, F. E., Bediaga, A., & Sáez, G. T. (2014) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-07320-0_2 · Cited by 62
Dong, Z., Zhuang, Q., Ye, X., Ning, M., Wu, S., Lu, L., & Wan, X. (2020) · Frontiers in Medicine · doi:10.3389/fmed.2020.546445 · Cited by 62
Urinary excretion of 8-oxo-7,8-dihydroguanine as biomarker of oxidative damage to DNA
Loft, S. H., Danielsen, P. H., Løhr, M., Jantzen, K., Hemmingsen, J. G., Roursgaard, M., Karottki, D. G., & Möller, P. (2012) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2011.12.026 · Cited by 61
Friederich‐Persson, M., Cat, A. N. D., Persson, P., Montezano, A. C. I., & Touyz, R. M. (2016) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.116.308659 · Cited by 61
Suárez‐Cuenca, J. A., la Peña‐Sosa, G. D., la Vega-Moreno, K. D., Banderas-Lares, D. Z., Salamanca-García, M., Martínez-Hernández, J. E., Vera‐Gómez, E., Hernández‐Patricio, A., Zamora-Alemán, C. R., Domínguez-Pérez, G. A., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-81289-2 · Cited by 61
Metabolic dysfunction and cancer in HCV: Shared pathways and mutual interactions
Leslie, J., Geh, D., Elsharkawy, A. M., Mann, D. A., & Vacca, M. (2022) · Journal of Hepatology · doi:10.1016/j.jhep.2022.01.029 · Cited by 61
Effects of free fatty acids on gluconeogenesis and glycogenolysis
Boden, G. H. (2002) · Life Sciences · doi:10.1016/s0024-3205(02)02350-0 · Cited by 60
Baker, J. F., Morales, M., Qatanani, M., Cucchiara, A. J., Nackos, E., Lazar, M. A., Teff, K. L., & Feldt, J. M. V. (2011) · The Journal of Rheumatology · doi:10.3899/jrheum.110237 · Cited by 60
Adipocytes promote breast tumorigenesis through TAZ-dependent secretion of Resistin
Gao, Y., Chen, X., He, Q. W., Gimple, R. C., Liao, Y., Wang, L., Wu, R., Xie, Q., Rich, J. N., Shen, K., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2005950117 · Cited by 60
Self-citationProgress in developing MNK inhibitors
Jin, X., Yu, R., Wang, X., Proud, C. G., & Jiang, T. (2021) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2021.113420 · Cited by 59
Self-citationPandey, K. N. (2011) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y11-054 · Cited by 57
Targeting the eIF4F translation initiation complex for cancer therapy
Konicek, B. W., Dumstorf, C. A., & Graff, J. R. (2008) · Cell Cycle · doi:10.4161/cc.7.16.6464 · Cited by 57
The major cap-binding protein eIF4E regulates lipid homeostasis and diet-induced obesity
Conn, C. S., Yang, H., Tom, H. J., Ikeda, K., Osés-Prieto, J. A., Vu, H., Oguri, Y., Nair, S., Gill, R. M., Kajimura, S., et al. (2021) · Nature Metabolism · doi:10.1038/s42255-021-00349-z · Cited by 57
Aging and physical function in type 2 diabetes: 8 years of an intensive lifestyle intervention
Rejeski, W. J., Bray, G. A., Chen, S.-H., Clark, J. M., Evans, M., Hill, J. O., Jakicic, J. M., Johnson, K. C., Neiberg, R., Ip, E. H., et al. (2015) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/glu083 · Cited by 56
Franssens, B. T., Hoogduin, H. M., Leiner, T., van der Graaf, Y., & Visseren, F. L. J. (2017) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.25594 · Cited by 56
Mahdaviani, K., Chess, D. J., Wu, Y., Shirihai, O. S., & Aprahamian, T. R. (2015) · Metabolism · doi:10.1016/j.metabol.2015.09.012 · Cited by 55
Obesity and the β cell: lessons from leptin
Niswender, K. D., & Magnuson, M. A. (2007) · Journal of Clinical Investigation · doi:10.1172/jci33528 · Cited by 51
Supraclavicular Brown Adipose Tissue 18F-FDG Uptake and Cardiovascular Disease
Takx, R. A. P., Ishai, A., Truong, Q. A., MacNabb, M. H., Scherrer‐Crosbie, M., & Tawakol, A. A. (2016) · Journal of Nuclear Medicine · doi:10.2967/jnumed.115.166025 · Cited by 51
COVID-19 and Obesity: Overlapping of Two Pandemics
Gammone, M. A., & D’Orazio, N. (2021) · Obesity Facts · doi:10.1159/000518386 · Cited by 50
Adiponectin, obesity and atherosclerosis
Behre, C. J. (2007) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.1080/00365510601158717 · Cited by 49
Blanca, A. J., Ruiz-Armenta, M. V., Zambrano, S. S., Salsoso, R., Miguel‐Carrasco, J. L., Fortuño, A., Revilla, E., Mate, A., & Vázquez, C. M. (2016) · Journal of Cellular Biochemistry · doi:10.1002/jcb.25526 · Cited by 49
Haas, B., Schlinkert, P., Mayer, P. E., & Eckstein, N. (2012) · Diabetology & Metabolic Syndrome · doi:10.1186/1758-5996-4-43 · Cited by 48
Clinical significance of serum adipokines levels in lung cancer
Kerenidi, T., Lada, M., Tsaroucha, A., Georgoulias, P., Mystridou, P., & Gourgoulianis, K. I. (2013) · Medical Oncology · doi:10.1007/s12032-013-0507-x · Cited by 47
Mechanistic Insights into the Link between Obesity and Prostate Cancer
Adesunloye, B. A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22083935 · Cited by 47
Habanjar, O., Diab‐Assaf, M., Caldefie‐Chezet, F., & Delort, L. (2022) · Biology · doi:10.3390/biology11020339 · Cited by 45
Morbid Obesity and Thyroid Cancer Rate. A Review of Literature
Masone, S., Velotti, N., Savastano, S., Filice, E., Serao, R., Vitiello, A., Berardi, G., Schiavone, V., & Musella, M. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10091894 · Cited by 42
MNK1 and MNK2 mediate adverse effects of high-fat feeding in distinct ways
Moore, C. E., Pickford, J., Cagampang, F. R. A., Stead, R., Tian, S., Zhao, X., Tang, X., Byrne, C. D., & Proud, C. G. (2016) · Scientific Reports · doi:10.1038/srep23476 · Cited by 41
Self-citationThe impact of obesity on heart failure
Zhai, A. B., & Haddad, H. A. (2017) · Current Opinion in Cardiology · doi:10.1097/hco.0000000000000370 · Cited by 41
The Role of Brown Adipose Tissue Dysfunction in the Development of Cardiovascular Disease
Chen, H., Meng, T., Gao, P., & Ruan, C. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.652246 · Cited by 41
Obesity and the increased risk for COVID-19: mechanisms and nutritional management
Morais, A. H. D. A., Passos, T. S., Vale, S. H. D. L., da Silva-Maia, J. K., & Maciel, B. L. L. (2020) · Nutrition Research Reviews · doi:10.1017/s095442242000027x · Cited by 40
Ayala‐Lopez, N., Thompson, J., & Watts, S. W. (2017) · Frontiers in Physiology · doi:10.3389/fphys.2017.00037 · Cited by 39
Ma, Y., & Liu, D. (2013) · Gene Therapy · doi:10.1038/gt.2013.8 · Cited by 38
Adiponectin and Thyroid Cancer: Insight into the Association between Adiponectin and Obesity
Zhou, Y., Yang, Y., Zhou, T., Li, B., & Wang, Z. (2021) · Aging and Disease · doi:10.14336/ad.2020.0919 · Cited by 38
Chang, Y., & Hung, H. (2022) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2022.114405 · Cited by 38
Effects of different weight loss approaches on CVD risk
Clifton, P. M., & Keogh, J. B. (2018) · Current Atherosclerosis Reports · doi:10.1007/s11883-018-0728-8 · Cited by 36
The Sirenic Links between Diabetes, Obesity, and Bladder Cancer
Gill, E., Sandhu, G., Ward, D. G., Perks, C. M., & Bryan, R. T. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222011150 · Cited by 36
Heparanase Accelerates Obesity-Associated Breast Cancer Progression
Hermano, E., Goldberg, R., Rubinstein, A. M., Sonnenblick, A., Maly, B., Nahmias, D., Li, J., Bakker, M. A. H., van der Vlag, J., Vlodavsky, I., et al. (2019) · Cancer Research · doi:10.1158/0008-5472.can-18-4058 · Cited by 35
Sandeman, L., Kang, W. X., Xuemin, W., Jensen, K. B., Wong, D., Bo, T., Gao, L., Zhao, J., Byrne, C. D., Page, A. J., et al. (2020) · Molecular Metabolism · doi:10.1016/j.molmet.2020.101054 · Cited by 34
Self-citationTriglycerides and Atherosclerosis
Toth, P. P. (2021) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2021.04.058 · Cited by 30
Efficacy comparison of medications approved for chronic weight management
Kumar, R. B., & Aronne, L. J. (2015) · Obesity · doi:10.1002/oby.21093 · Cited by 29
Leptin level as a biomarker of uncontrolled eating in obesity and overweight
Benbaibeche, H., Bounihi, A., & Koceir, E.-A. (2020) · Irish Journal of Medical Science (1971 -) · doi:10.1007/s11845-020-02316-1 · Cited by 29
Cardiomyocyte apoptosis in animal models of obesity
Trivedi, P. S., & Barouch, L. A. (2008) · Current Hypertension Reports · doi:10.1007/s11906-008-0085-z · Cited by 28
Early ROS-mediated DNA damage and oxidative stress biomarkers in Monoclonal B Lymphocytosis
Collado, R., Oliver, I., Tormos, C., Egea, M., Miguel, A., Cerdá, C., Ivars, D., Borrego, S., Carbonell, F., & Sáez, G. T. (2011) · Cancer Letters · doi:10.1016/j.canlet.2011.11.018 · Cited by 28
Wolsk, E., Mygind, H. W., Grøndahl, T. S., Pedersen, B. K., & van Hall, G. (2011) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.111.012260 · Cited by 27
Adipocytokine levels of colon cancer patients before and after treatment
Kosova, F., Coşkun, T., Kaya, Y., Kara, E., & Arı, Z. (2013) · Bratislavské lekárske listy/Bratislava medical journal · doi:10.4149/bll_2013_083 · Cited by 27
Maugeri, A., Hrusková, J., Jakubík, J., Barchitta, M., Re, O. L., Kunzová, Š., Medina‐Inojosa, J. R., Agodi, A., Sciacca, S., & Vinciguerra, M. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8030370 · Cited by 27
Ding, L., Kang, Y., Dai, H., Wang, F., Zhou, Y., Gao, Q., Xiong, X., Zhang, F., Song, T., Yuan, Y., et al. (2019) · Journal of Translational Medicine · doi:10.1186/s12967-019-2006-0 · Cited by 27
Heart Failure Development in Obesity: Underlying Risk Factors and Mechanistic Pathways
Jamaly, S., Carlsson, L. M. S., Peltonen, M., Andersson‐Assarsson, J. C., & Karason, K. (2020) · ESC Heart Failure · doi:10.1002/ehf2.13081 · Cited by 27
Atrial natriuretic peptide and regulation of vascular function in hypertension and heart failure
Rubattu, S., Calvieri, C., Pagliaro, B., & Volpe, M. (2013) · Journal of Hypertension · doi:10.1097/hjh.0b013e32835ed5eb · Cited by 25
Farag, K., Makkouk, A., & Norian, L. A. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.668494 · Cited by 24
The Role of Notch Signaling and Leptin-Notch Crosstalk in Pancreatic Cancer
Harbuzariu, A., Oprea‐Ilies, G., & Gonzalez-Perez, R. R. (2018) · Medicines · doi:10.3390/medicines5030068 · Cited by 23
Pharmacotherapy for obesity in individuals with type 2 diabetes
Chukir, T., Shukla, A. P., Saunders, K. H., & Aronne, L. J. (2018) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2018.1428558 · Cited by 22
Deciphering the mechanistic effects of eIF4E phosphorylation on mRNA‐cap recognition
Lama, D., & Verma, C. S. (2019) · Protein Science · doi:10.1002/pro.3798 · Cited by 21
Adipose Tissue and Atherosclerosis
Poledne, R., Lesná, I. K., & Čejková, S. (2015) · Physiological Research · doi:10.33549/physiolres.933152 · Cited by 14
Breininger, S. P., Sabater, L., Malcomson, F. C., Afshar, S., Mann, J., & Mathers, J. C. (2021) · International Journal of Obesity · doi:10.1038/s41366-021-01005-y · Cited by 11
Belaj, K., & Eller, P. (2011) · Gerontology · doi:10.1159/000331798 · Cited by 9
Thyroid function and atrial fibrillation: Is there a mediating role for epicardial adipose tissue?
Bos, D., Bano, A., Albert Hofman, D., VanderWeele, T. J., Kavousi, M., Franco, O. H., Vernooij, M. W., Peeters, R. P., Ikram, M. A., & Chaker, L. (2018) · Clinical Epidemiology · doi:10.2147/clep.s149151 · Cited by 7
Leptin Levels are Associated with Subclinical Cardiac Dysfunction in Obese Adolescents
Imerbtham, T., Thitiwuthikiat, P., Jongjitwimol, J., Nuamchit, T., Yingchoncharoen, T., & Siriwittayawan, D. (2020) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s245048 · Cited by 7
Effect of obesity on several types of cancer
Zhao, Y., & Yang, T. (2021) · E3S Web of Conferences · doi:10.1051/e3sconf/202129203083 · Cited by 2
Research works printed but not linked: 7
- Ottaiano, 2018, Obesity and cancer: biological links and treatment implications, Curr Cancer Drug Targets, 18, 231, 10.2174/1568009617666170330125619 · doi:10.2174/1568009617666170330125619
- Ohbuchi, 2014, A lower serum level of middle-molecular-weight adiponectin is a risk factor for endometrial cancer, Int J Clin Oncol, 19, 667, 10.1007/s10147-013-0603-0 · doi:10.1007/s10147-013-0603-0
- Bujak-Gizycka, 2007, Measurement of angiotensin metabolites in organ bath and cell culture experiments by liquid chromatography–electrospray ionization–mass spectrometry (LC–ESI–MS), J Physiol Pharmacol, 58, 529
- Askin, 2022, Resistin and cardiovascular disease: a review of the current literature regarding clinical and pathological relationships, Curr Cardiol Rev, 18, 70, 10.2174/1573403X17666210729101120 · doi:10.2174/1573403x17666210729101120
- Januzzi, 2021, Obesity-mediated disruption of natriuretic peptide–blood pressure rhythms, J Am Coll Cardiol, 77, 2304, 10.1016/j.jacc.2021.03.317 · doi:10.1016/j.jacc.2021.03.317
- Shintani, 2000, Insulin resistance, role of leptin and leptin receptor, Nihon Rinsho, 58, 327
- Marrero, 2019, Obesity and liver disease: the new era of liver transplantation, Hepatology, 70, 459, 10.1002/hep.30854 · doi:10.1002/hep.30854
Cited by
Tasabehji, D., Saleh, S., & Mokadem, M. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14124012 · Cited by 14
Metadata
- Authors
- Jin, X., Qiu, T., Li, L., Yu, R., Chen, X., Li, C., Proud, C. G., & Jiang, T.
- Venue
- Acta Pharmaceutica Sinica B
- Publisher
- Elsevier BV
- Published
- 2023-06
- Volume
- 13
- Issue
- 6
- Pages
- 2403-2424
- ISSN
- 2211-3835 (ISSN-L)
- OpenAlex
- W4316037741
- Cited by
- 499
- References
- 361
- FWCI
- 83.29
- Type
- journal article
- Language
- en
- Open access
- gold
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- creativecommons.org/licenses/by-nc-nd/4.0/ (vor)
- Funders
- Qingdao Postdoctoral Science Foundation (862105040014)
- National Natural Science Foundation of China (82073759)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.